Diphtheria, tetanus and inactivated poliomyelitis vaccine: patient group direction template

Guidance DIPHTHERIA, TETANUS AND INACTIVATED POLIOMYELITIS VACCINE: PATIENT GROUP DIRECTION TEMPLATE Patient group direction (PGD) template to support the national diphtheria, tetanus and

inactivated poliomyelitis (Td/IPV – Revaxis®) vaccination programme. Get emails about this page APPLIES TO ENGLAND DOCUMENTS DIPHTHERIA, TETANUS AND INACTIVATED POLIOMYELITIS VACCINE (TD/IPV

– REVAXIS®): PATIENT GROUP DIRECTION (PGD) TEMPLATE Ref: UKHSA publications gateway number: GOV-16527 MS Word Document, 250 KB This file may not be suitable for users of assistive

technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email

[email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use. DETAILS This PGD template supports the administration of

diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV), to individuals from 10 years of age, in accordance with national immunisation programme, for travel or for the management

of cases and contacts of diphtheria, tetanus or poliomyelitis. Td/IPV (Revaxis®) PGD version 6.00 is valid from 4 August 2024 to 4 August 2026. Practitioners must not use this PGD template

until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised

PGD documents. This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine. SIGN UP FOR EMAILS OR

PRINT THIS PAGE Get emails about this page Print this page